Skip to main content
Clinical Trials/ISRCTN55153521
ISRCTN55153521
Completed
未知

The role of inhaled corticosteroids in children with chronic lung disease of Infancy

niversity of Calgary (Canada)0 sites82 target enrollmentMarch 22, 2005

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Calgary (Canada)
Enrollment
82
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Registry
who.int
Start Date
March 22, 2005
End Date
December 31, 2005
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Calgary (Canada)

Eligibility Criteria

Inclusion Criteria

  • 1\. 3 \- 7 year old children with history of chronic lung disease of infancy
  • 2\. Premature birth at 36 weeks gestation or less
  • 3\. Clinical and radiological diagnosis of CLD. Patient charts will be reviewed and the x\-rays will be reviewed, even if there is no x\-ray findings patients will be included if they fulfil the other criteria.
  • 4\. Requirement of supplemental oxygen to maintain saturation of 90%, for at least 36 weeks corrected gestation

Exclusion Criteria

  • 1\. Cardiovascular disease other than patent ductus arteriosus (PDA)
  • 2\. Those with severe neurological disease or developmental delay
  • 3\. Oxygen requirement for respiratory diagnosis other than CLD, e.g., congenital diaphragmatic hernia and aspiration
  • 4\. An inability to perform spirometry or impulse oscillometry (IOS)
  • 5\. Noncompliance with therapy
  • 6\. Pneumonia

Outcomes

Primary Outcomes

Not specified

Similar Trials